Body Mass Index and the Development of New-Onset Diabetes Mellitus or the Worsening of Pre-Existing Diabetes Mellitus in Adult Kidney Transplant Patients

Tysen J. Cullen, Maureen P. McCarthy, Michael R. Lasarev, John Barry, Diane Stadler

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: The purpose of this study was to determine the relationship between body mass index (BMI) and the development of new-onset diabetes after transplant (NODAT) as well as the worsening of pre-existing diabetes mellitus (DM) in adults after kidney transplantation. Design and Subjects: A medical record review was conducted using the records of 204 adult patients who underwent a first renal transplant between September 2009 and February 2011 at a single transplant center. Patients who received simultaneous transplantation of another organ, who were immunosuppressed for nontransplant reasons, or those who were less than 18years of age were excluded. Main Outcome Measures: Outcome data collected at the time of hospital discharge and at 3, 6, and 12months after kidney transplantation included the development of NODAT and the components of DM treatment regimens. Results: The cumulative incidence of NODAT at discharge and 3, 6, and 12months post-transplantation was 14.2%, 19.4%, 20.1%, and 19.4%, respectively. The odds of developing NODAT by discharge or 3 or 6months post-transplantation increased by a factor of 1.11 (95% confidence interval [CI]: 1.0-1.23), 1.13 (95% CI: 1.03-1.24), and 1.15 (95% CI: 1.05-1.27), respectively, per unit increase in pretransplantation BMI. The need for more aggressive DM treatment (suggesting a worsening of DM status) was most usually seen between discharge and 3months; 50% of patients with preexisting DM required more aggressive DM treatment post-transplantation (X3 2 = 13.25; P= 001). Conclusion: The odds of developing NODAT at discharge and 3 and 6months post-transplantation increased per unit of pretransplantation BMI. The most common time for NODAT to develop or for preexisting DM to worsen was within 3months of kidney transplantation.

Original languageEnglish (US)
Pages (from-to)116-122
Number of pages7
JournalJournal of Renal Nutrition
Volume24
Issue number2
DOIs
StatePublished - Mar 2014

Fingerprint

Diabetes Mellitus
Body Mass Index
Transplants
Kidney
Transplantation
Kidney Transplantation
Confidence Intervals
Organ Transplantation
Medical Records
Therapeutics
Outcome Assessment (Health Care)
Incidence

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics
  • Nephrology

Cite this

Body Mass Index and the Development of New-Onset Diabetes Mellitus or the Worsening of Pre-Existing Diabetes Mellitus in Adult Kidney Transplant Patients. / Cullen, Tysen J.; McCarthy, Maureen P.; Lasarev, Michael R.; Barry, John; Stadler, Diane.

In: Journal of Renal Nutrition, Vol. 24, No. 2, 03.2014, p. 116-122.

Research output: Contribution to journalArticle

@article{3b2fa865203f4bce92fa4ce56d2567d7,
title = "Body Mass Index and the Development of New-Onset Diabetes Mellitus or the Worsening of Pre-Existing Diabetes Mellitus in Adult Kidney Transplant Patients",
abstract = "Objective: The purpose of this study was to determine the relationship between body mass index (BMI) and the development of new-onset diabetes after transplant (NODAT) as well as the worsening of pre-existing diabetes mellitus (DM) in adults after kidney transplantation. Design and Subjects: A medical record review was conducted using the records of 204 adult patients who underwent a first renal transplant between September 2009 and February 2011 at a single transplant center. Patients who received simultaneous transplantation of another organ, who were immunosuppressed for nontransplant reasons, or those who were less than 18years of age were excluded. Main Outcome Measures: Outcome data collected at the time of hospital discharge and at 3, 6, and 12months after kidney transplantation included the development of NODAT and the components of DM treatment regimens. Results: The cumulative incidence of NODAT at discharge and 3, 6, and 12months post-transplantation was 14.2{\%}, 19.4{\%}, 20.1{\%}, and 19.4{\%}, respectively. The odds of developing NODAT by discharge or 3 or 6months post-transplantation increased by a factor of 1.11 (95{\%} confidence interval [CI]: 1.0-1.23), 1.13 (95{\%} CI: 1.03-1.24), and 1.15 (95{\%} CI: 1.05-1.27), respectively, per unit increase in pretransplantation BMI. The need for more aggressive DM treatment (suggesting a worsening of DM status) was most usually seen between discharge and 3months; 50{\%} of patients with preexisting DM required more aggressive DM treatment post-transplantation (X3 2 = 13.25; P= 001). Conclusion: The odds of developing NODAT at discharge and 3 and 6months post-transplantation increased per unit of pretransplantation BMI. The most common time for NODAT to develop or for preexisting DM to worsen was within 3months of kidney transplantation.",
author = "Cullen, {Tysen J.} and McCarthy, {Maureen P.} and Lasarev, {Michael R.} and John Barry and Diane Stadler",
year = "2014",
month = "3",
doi = "10.1053/j.jrn.2013.11.002",
language = "English (US)",
volume = "24",
pages = "116--122",
journal = "Journal of Renal Nutrition",
issn = "1051-2276",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Body Mass Index and the Development of New-Onset Diabetes Mellitus or the Worsening of Pre-Existing Diabetes Mellitus in Adult Kidney Transplant Patients

AU - Cullen, Tysen J.

AU - McCarthy, Maureen P.

AU - Lasarev, Michael R.

AU - Barry, John

AU - Stadler, Diane

PY - 2014/3

Y1 - 2014/3

N2 - Objective: The purpose of this study was to determine the relationship between body mass index (BMI) and the development of new-onset diabetes after transplant (NODAT) as well as the worsening of pre-existing diabetes mellitus (DM) in adults after kidney transplantation. Design and Subjects: A medical record review was conducted using the records of 204 adult patients who underwent a first renal transplant between September 2009 and February 2011 at a single transplant center. Patients who received simultaneous transplantation of another organ, who were immunosuppressed for nontransplant reasons, or those who were less than 18years of age were excluded. Main Outcome Measures: Outcome data collected at the time of hospital discharge and at 3, 6, and 12months after kidney transplantation included the development of NODAT and the components of DM treatment regimens. Results: The cumulative incidence of NODAT at discharge and 3, 6, and 12months post-transplantation was 14.2%, 19.4%, 20.1%, and 19.4%, respectively. The odds of developing NODAT by discharge or 3 or 6months post-transplantation increased by a factor of 1.11 (95% confidence interval [CI]: 1.0-1.23), 1.13 (95% CI: 1.03-1.24), and 1.15 (95% CI: 1.05-1.27), respectively, per unit increase in pretransplantation BMI. The need for more aggressive DM treatment (suggesting a worsening of DM status) was most usually seen between discharge and 3months; 50% of patients with preexisting DM required more aggressive DM treatment post-transplantation (X3 2 = 13.25; P= 001). Conclusion: The odds of developing NODAT at discharge and 3 and 6months post-transplantation increased per unit of pretransplantation BMI. The most common time for NODAT to develop or for preexisting DM to worsen was within 3months of kidney transplantation.

AB - Objective: The purpose of this study was to determine the relationship between body mass index (BMI) and the development of new-onset diabetes after transplant (NODAT) as well as the worsening of pre-existing diabetes mellitus (DM) in adults after kidney transplantation. Design and Subjects: A medical record review was conducted using the records of 204 adult patients who underwent a first renal transplant between September 2009 and February 2011 at a single transplant center. Patients who received simultaneous transplantation of another organ, who were immunosuppressed for nontransplant reasons, or those who were less than 18years of age were excluded. Main Outcome Measures: Outcome data collected at the time of hospital discharge and at 3, 6, and 12months after kidney transplantation included the development of NODAT and the components of DM treatment regimens. Results: The cumulative incidence of NODAT at discharge and 3, 6, and 12months post-transplantation was 14.2%, 19.4%, 20.1%, and 19.4%, respectively. The odds of developing NODAT by discharge or 3 or 6months post-transplantation increased by a factor of 1.11 (95% confidence interval [CI]: 1.0-1.23), 1.13 (95% CI: 1.03-1.24), and 1.15 (95% CI: 1.05-1.27), respectively, per unit increase in pretransplantation BMI. The need for more aggressive DM treatment (suggesting a worsening of DM status) was most usually seen between discharge and 3months; 50% of patients with preexisting DM required more aggressive DM treatment post-transplantation (X3 2 = 13.25; P= 001). Conclusion: The odds of developing NODAT at discharge and 3 and 6months post-transplantation increased per unit of pretransplantation BMI. The most common time for NODAT to develop or for preexisting DM to worsen was within 3months of kidney transplantation.

UR - http://www.scopus.com/inward/record.url?scp=84894245132&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894245132&partnerID=8YFLogxK

U2 - 10.1053/j.jrn.2013.11.002

DO - 10.1053/j.jrn.2013.11.002

M3 - Article

C2 - 24411665

AN - SCOPUS:84894245132

VL - 24

SP - 116

EP - 122

JO - Journal of Renal Nutrition

JF - Journal of Renal Nutrition

SN - 1051-2276

IS - 2

ER -